In this edition of Clinical Lab Chat, Director of Business Intelligence Chris Wolski discusses with Courtney Noah, PhD, VP of Scientific Affairs at BioIVT, how blood-based biofluid testing is poised to revolutionize cancer diagnostics.

Among the topics they dig into are:

• The benefits of blood-based biofluid testing over traditional, more invasive methods.
• How biofluid testing saves money and improves access for patients.
• How labs can add blood-based biofluid testing onto their diagnostic menus.
• The importance of proper sample collection.
• The renaissance in the use of blood-based biomarkers in diagnostic testing.